Stocks and Investing Stocks and Investing
Thu, February 13, 2025

Corcept Therapeutics stock soars to all-time high of $71.3


Published on 2025-02-13 11:41:15 - MSN
  Print publication without navigation

  • Corcept Therapeutics Incorporated (NASDAQ:CORT) has reached an unprecedented milestone as its stock price soared to an all-time high of $71.3. According to InvestingPro data, the company maintains a "GREAT" financial health score and has achieved impressive revenue growth of ~40% over the last twelve months.

Corcept Therapeutics Inc.'s stock surged to an all-time high of $71.30, driven by positive developments in its clinical trials and market expansion. The company, known for its focus on treatments for severe metabolic, oncologic, and psychiatric disorders, announced promising results from its ongoing studies, particularly for its lead drug, Korlym, used in treating Cushing's syndrome. Additionally, Corcept has been expanding its research into new indications for Korlym and other pipeline drugs, which has bolstered investor confidence. The stock's rise reflects not only the company's strong performance but also the growing market interest in specialized pharmaceuticals addressing unmet medical needs.

Read the Full MSN Article at:
[ https://www.msn.com/en-us/money/top-stocks/corcept-therapeutics-stock-soars-to-all-time-high-of-71-3/ar-AA1yZsEt ]
Contributing Sources